Cardiovascular outcomes & atherosclerosis: How do GLP-1 receptor antagonist provide benefits?

31 August 2020 (18:50 - 19:05)
Organised by:
Congress Presentation Part of: Expanding focus for cardiologists: The diabetic patient and cardiovascular outcomes Diabetes and the Heart Open Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by